Retraction Note: BCORL1 is an independent prognostic marker and contributes to cell migration and invasion in human hepatocellular carcinoma

Guozhi Yin, Zhikui Liu, Yufeng Wang, Changwei Dou, Chao Li, Wei Yang, Yingmin Yao, Qingguang Liu, Kangsheng TuBMC 2023 · DOI · OpenAlex

Introduction

In 2016, a study published in BMC Cancer proposed that BCORL1 (BCL6 corepressor-like 1) acted as an independent prognostic marker and a driver of metastasis in human hepatocellular carcinoma (HCC). However, following an editorial investigation into the integrity of the presented data, the journal has formally retracted the article. This note summarizes the reasons for the retraction and the resulting implications for liver cancer research.

The Original Research Context

Hepatocellular carcinoma is the most prevalent form of primary liver cancer and a leading cause of cancer-related mortality worldwide. The original study aimed to address the urgent need for biomarkers that could predict patient outcomes and serve as targets for anti-metastatic therapies. The authors initially reported that BCORL1 was significantly overexpressed in HCC tissues compared to adjacent healthy tissues. Their data suggested a correlation between high BCORL1 levels and poor patient prognosis, claiming the protein promoted cell migration and invasion—key steps in the metastatic cascade.

Identification of Data Irregularities

The retraction was primarily driven by the discovery of "irregularities" in the image data, specifically within Figure 3. Editorial audits, often supported by automated image-analysis tools or post-publication peer review, identified that several microscopy panels meant to represent different experimental groups were overlapping or identical.

In the original study, the authors utilized Transwell assays to measure:

  • Cell Migration: The movement of cells through a porous membrane.
  • Cell Invasion: The ability of cells to degrade an extracellular matrix to pass through a membrane.

The retraction note specifically highlights Figure 3B and 3D, where images intended to show migration were found to be duplicates of those showing invasion. Because these represent distinct biological processes, such overlaps suggest either a severe failure in data management or intentional manipulation.

Loss of Editorial Confidence

A critical factor in the decision to retract was the authors' lack of engagement. The journal's editorial board reached out to the research team to request the original, unprocessed data files and an explanation for the figure overlaps. According to the formal notice, "None of the authors has responded to correspondence about this retraction."

In academic publishing, the inability or refusal to provide raw data when discrepancies are identified typically results in a total loss of confidence. Consequently, the editors determined that the study’s conclusions—both the quantitative statistical correlations and the qualitative microscopy results—could no longer be considered reliable.

Implications for the Scientific Record

This retraction serves as a reminder of the challenges in maintaining the integrity of the scientific literature. The seven-year gap between the paper's publication in 2016 and its retraction in 2023 illustrates the persistence of flawed data in the record and the ongoing efforts required to correct it.

For the oncology community, the primary takeaway is that the status of BCORL1 as a prognostic marker in HCC remains unproven. While the protein may still play a role in cancer biology, the evidence provided in the 2016 study is now void.

Conclusion and Future Directions

The formal withdrawal of this paper necessitates a cautious approach to any future research involving BCORL1 in the context of liver cancer. Independent validation by other laboratories using transparent, open-data practices is required to determine if the initial hypotheses regarding BCORL1 hold any merit. Furthermore, this case underscores the necessity for journals to implement more rigorous image-screening protocols during the initial peer-review phase to prevent the publication of compromised data.

Summary updated

BibTeX
@inproceedings{yin2023retraction,
  author = {Guozhi Yin and Zhikui Liu and Yufeng Wang and Changwei Dou and Chao Li and Wei Yang and Yingmin Yao and Qingguang Liu and Kangsheng Tu},
  title = {{Retraction Note: BCORL1 is an independent prognostic marker and contributes to cell migration and invasion in human hepatocellular carcinoma}},
  booktitle = {BMC},
  year = {2023},
  doi = {10.1186/s12885-023-11051-6},
}
Figure